Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Moodys
Accenture
Teva
Colorcon
QuintilesIMS
McKinsey
Boehringer Ingelheim
Cerilliant
US Army

Generated: October 19, 2017

DrugPatentWatch Database Preview

PROAMATINE Drug Profile

« Back to Dashboard

Which patents cover Proamatine, and when can generic versions of Proamatine launch?

Proamatine is a drug marketed by Shire Llc and is included in one NDA.

The generic ingredient in PROAMATINE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

Summary for Tradename: PROAMATINE

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list54
Clinical Trials: see list10
Patent Applications: see list230
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROAMATINE at DailyMed

Pharmacology for Tradename: PROAMATINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Llc
PROAMATINE
midodrine hydrochloride
TABLET;ORAL019815-001Sep 6, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Shire Llc
PROAMATINE
midodrine hydrochloride
TABLET;ORAL019815-002Sep 6, 1996DISCNYesNo► Subscribe► Subscribe► Subscribe
Shire Llc
PROAMATINE
midodrine hydrochloride
TABLET;ORAL019815-003Mar 20, 2002DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Argus Health
Cerilliant
US Army
Federal Trade Commission
Julphar
Daiichi Sankyo
US Department of Justice
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot